Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

1,000 patients to help unlock secrets of liver surgery recovery

NCT ID NCT07556835

Knowledge-focused Sponsor: Azienda USL Toscana Centro Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will follow 1,000 adults who have liver or bile duct surgery at one hospital in Italy. Researchers will track complications, survival, and cancer recurrence for up to 5 years. The goal is to better understand what affects recovery and long-term health after these operations.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could help doctors better predict surgical risks and long-term outcomes for patients with liver or bile duct diseases.
What could go wrong
This is an observational study, not a test of a new treatment. It only collects existing data, so it cannot prove what causes better or worse outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 1,000 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Apr 2026

An estimate. Start dates often move.

Expected to finish

Dec 2036

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult patients undergoing liver and/or biliary resection for benign or malignant hepatobiliary diseases at San Jacopo Hospital, Pistoia, a high-volume hepatobiliary center. The study includes both a retrospective cohort (2015-2025) and a prospective cohort (2026-2031).

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥ 18 years * Patients undergoing liver resection and/or biliary resection at San Jacopo Hospital, Pistoia * Diagnosis of benign or malignant hepatobiliary disease * Availability of clinical, surgical, and follow-up data * For the prospective cohort, provision of written informed consent when required according to local regulations Exclusion Criteria: * Age \< 18 years * Pregnancy * No liver or biliary resection performed * Biopsy only without resection * Refusal or unavailability of consent for the prospective cohort when consent is required

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Benign liver disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

biliary tract disorder cholangiocarcinoma Digestive System Diseases gallbladder carcinoma gallbladder neoplasm hepatobiliary disorder hepatocellular carcinoma liver and intrahepatic bile duct neoplasm liver disorder Liver Neoplasms Postoperative Complications

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Benign liver disease Biliary tract diseases Cholangiocarcinoma Gallbladder carcinoma Hepatobiliary diseases Hepatocellular carcinoma Liver metastases Liver metastases from colorectal cancer Liver neoplasms

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • San Jacopo Hospital

    Pistoia, Tuscany, 51100, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.